Literature DB >> 10634924

Thiamin deficiency in HIV-positive patients: evaluation by erythrocyte transketolase activity and thiamin pyrophosphate effect.

R M Müri1, J Von Overbeck, J Furrer, P E Ballmer.   

Abstract

BACKGROUND AND AIMS: The aim of the study was to determine the thiamin status in HIV-positive patients.
METHODS: Measurement of erythrocyte transketolase activity (ETK) and thiaminpyrophosphate (TPP) effect in 55 consecutive HIV-positive patients of a specialized outpatient clinic were grouped into five groups according to their CD4 counts. Comparison of results of HIV-positive patients with age-matched control group of 22 healthy subjects.
RESULTS: Of the patients, 27% had a pathologically-increased TPP effect, 18% of the patients had pathologically-low ETK. The percentage of pathological values of TPP effect in the patients was significantly higher compared with the control group. There was no statistically significant correlation between pathological thiamin status and stage of the disease, zidovudine therapy or nutritional status of the patients.
CONCLUSIONS: Thiamin deficiency in HIV-positive patients was found in a higher percentage than previously reported. Thiamine deficiency is not only present in advanced stages of HIV-infection, but also in clinically asymptomatic patients. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10634924     DOI: 10.1016/s0261-5614(99)80019-3

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  5 in total

1.  Cognitive and Motor Impairment Severity Related to Signs of Subclinical Wernicke's Encephalopathy in HIV Infection.

Authors:  Anne-Pascale Le Berre; Rosemary Fama; Stephanie A Sassoon; Adolf Pfefferbaum; Edith V Sullivan; Natalie M Zahr
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

2.  Thiamine status in humans and content of phosphorylated thiamine derivatives in biopsies and cultured cells.

Authors:  Marjorie Gangolf; Jan Czerniecki; Marc Radermecker; Olivier Detry; Michelle Nisolle; Caroline Jouan; Didier Martin; Frédéric Chantraine; Bernard Lakaye; Pierre Wins; Thierry Grisar; Lucien Bettendorff
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

3.  Drug-nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3).

Authors:  Bianca Vora; Elizabeth A E Green; Natalia Khuri; Frida Ballgren; Marina Sirota; Kathleen M Giacomini
Journal:  Am J Clin Nutr       Date:  2020-01-01       Impact factor: 7.045

Review 4.  What We Know So Far about the Metabolite-Mediated Microbiota-Intestinal Immunity Dialogue and How to Hear the Sound of This Crosstalk.

Authors:  Clément Caffaratti; Caroline Plazy; Geoffroy Mery; Abdoul-Razak Tidjani; Federica Fiorini; Sarah Thiroux; Bertrand Toussaint; Dalil Hannani; Audrey Le Gouellec
Journal:  Metabolites       Date:  2021-06-21

5.  A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives.

Authors:  Derrick Lonsdale
Journal:  Evid Based Complement Alternat Med       Date:  2006-03       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.